We use the same rate as awarded.

Charlotte A. Johnson
Director,  Office of Sponsored Programs
Harvard Pilgrim Health Care
133 Brookline Ave., 5th Floor
Boston, MA 02215
Telephone:  617/509-9929
Fax:  617/509-9859
www.harvardpilgrim.org/providers (research and teaching)

From:	"Solano, Frances" <xxxxxx@COH.ORG>
To:	xxxxxx@lists.healthresearch.org
Date:	09/13/2011 01:23 PM
Subject:	[RESADM-L] charging indirect rates for A-122 institutions (non-profits)
Sent by:	Research Administration List <xxxxxx@lists.healthresearch.org>

A-21 is pretty clear about charging the indirect rate that’s in effect at the time of the award.
But I do not see anything clearly stated in A-122.  Our institution has historically adjusted the
applied indirect rate as rates have been negotiated during the life of the award, but we are hearing
from NIH that we should keep the same rate.  How do other non-profits do this?
Thanks for your input.

******************************************************
 Frances A. Solano
 Director, Office of Sponsored Research
 City of Hope / Beckman Research Institute
 1500 East Duarte Road, Mod 103
 Duarte, CA  91010-3000
 Phone:  626-256-HOPE (4673), ext. 62191
 Fax:  626-256-8843
 Email:  xxxxxx@coh.org
 URL:  www.cityofhope.org
********************************************************

---------------------------------------------------------------------
*SECURITY/CONFIDENTIALITY WARNING: This message and any attachments are intended solely for the
individual or entity to which they are addressed. This communication may contain information that is
privileged, confidential, or exempt from disclosure under applicable law (e.g., personal health
information, research data, financial information). Because this e-mail has been sent without
encryption, individuals other than the intended recipient may be able to view the information,
forward it to others or tamper with the information without the knowledge or consent of the sender.
If you are not the intended recipient, or the employee or person responsible for delivering the
message to the intended recipient, any dissemination, distribution or copying of the communication
is strictly prohibited. If you received the communication in error, please notify the sender
immediately by replying to this message and deleting the message and any accompanying files from
your system. If, due to the security risks, you do not wish to receive further communications via
e-mail, please reply to this message and inform the sender that you do not wish to receive further
e-mail from the sender.
---------------------------------------------------------------------

====================================================================== Instructions on how to use
the RESADM-L Mailing List, including subscription information and a web-searchable archive, are
available via our web site at http://www.healthresearch.org (click on the "LISTSERV" link in the
upper right corner)

A link directly to helpful tips: http://tinyurl.com/resadm-l-help
======================================================================

------------------------------------------------------------------
The information contained in this email message and any attachments may be privileged and/or confidential.  It is for intended addressee(s) only.  If you are not the intended recipient, you are hereby notified that any review, disclosure, reproduction, distribution or other use of this communication is strictly prohibited.  If you received this email in error, please notify the sender by reply and delete the message without saving, copying or disclosing it.  Thank you.

======================================================================
 Instructions on how to use the RESADM-L Mailing List, including
 subscription information and a web-searchable archive, are available
 via our web site at http://www.healthresearch.org (click on the
 "LISTSERV" link in the upper right corner)

 A link directly to helpful tips:  http://tinyurl.com/resadm-l-help
======================================================================